Last updated on July 2018

HUMIRA Long-term Treatment in Patients With Non-infectious Intermediate- Posterior- or Pan-uveitis


Brief description of study

This study evaluates the long- term safety and effectiveness of adalimumab in participants with non-infectious intermediate-, posterior-, or pan-uveitis in daily practice in Japan.

Clinical Study Identifier: NCT02916017

Contact Investigators or Research Sites near you

Start Over

AbbVie GK Clinical Trial Registration ...

Juntendo Univ Urayasu Hosp
Urayasu Shi, Japan

AbbVie GK Clinical Trial Registration ...

Matsuyama Red Cross Hosp
Matsuyama, Japan

AbbVie GK Clinical Trial Registration ...

Kyushu University Hospital
Fukuoka-shi, Japan

AbbVie GK Clinical Trial Registration ...

Kurume University Hospital
Kurume-shi, Japan

AbbVie GK Clinical Trial Registration ...

Gunma University Hospital
Maebashi-shi, Japan

AbbVie GK Clinical Trial Registration ...

Kobe University Hospital
Kobe, Japan

AbbVie GK Clinical Trial Registration ...

Kanazawa University Hospital
Kanazawa, Japan